{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:32:15Z","timestamp":1792740735260,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.atherosclerosis.2007.12.055","type":"journal-article","created":{"date-parts":[[2008,3,6]],"date-time":"2008-03-06T23:04:11Z","timestamp":1204844651000},"page":"126-134","source":"Crossref","is-referenced-by-count":18,"title":["Introducing the first polymer-free leflunomide eluting stent"],"prefix":"10.1016","volume":"200","author":[{"given":"Tobias","family":"Deuse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold G.","family":"Erben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Ikeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Behnisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Boeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Reichenspurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bergow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc P.","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Robbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Schrepfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.atherosclerosis.2007.12.055_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ahj.2006.03.005","article-title":"Patterns and outcomes of drug-eluting coronary stent use in clinical practice","volume":"152","author":"Rao","year":"2006","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2007.12.055_bib2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.ahj.2007.02.016","article-title":"Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction","volume":"153","author":"Pasceri","year":"2007","journal-title":"Am Heart J"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2007.12.055_bib3","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1161\/CIRCULATIONAHA.106.667592","article-title":"Long-term safety and efficacy of drug-eluting stents: 2-year results of the REAL (REgistro AngiopLastiche dell\u2019Emilia Romagna) multicenter registry","volume":"115","author":"Marzocchi","year":"2007","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2007.12.055_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2007.12.055_bib5","doi-asserted-by":"crossref","first-page":"392","DOI":"10.7326\/0003-4819-143-5-200509060-00119","article-title":"Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent","author":"Wessely","year":"2005","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2007.12.055_bib6","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.jacc.2006.10.026","article-title":"Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents","volume":"48","author":"Pfisterer","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2007.12.055_bib7","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/01.CIR.0000116202.41966.D4","article-title":"Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?","volume":"109","author":"Virmani","year":"2004","journal-title":"Circulation"},{"issue":"9444","key":"10.1016\/j.atherosclerosis.2007.12.055_bib8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","article-title":"Late thrombosis in drug-eluting coronary stents after discontinuation of anti-platelet therapy","volume":"364","author":"McFadden","year":"2004","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2007.12.055_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/hrt.2005.068288","article-title":"The future of drug eluting stents","volume":"92","author":"Anis","year":"2006","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2007.12.055_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1517\/14656566.6.5.787","article-title":"Leflunomide: long-term clinical experience and new uses","volume":"6","author":"Kaltwasser","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2007.12.055_bib11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.ATV.0000157579.52566.ee","article-title":"Inhibition of neointima formation by a novel drug-eluting stent system that allows for dose-adjustable, multiple, and on-site stent coating.","volume":"25","author":"Wessely","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2007.12.055_bib12","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1161\/01.CIR.0000033485.20594.6F","article-title":"Drug-eluting stents in preclinical studies: recommended evaluation from a consensus group","volume":"106","author":"Schwartz","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2007.12.055_bib13","first-page":"297","article-title":"Drug-eluting stents","volume":"76","author":"Garc\u00eda-Garc\u00eda","year":"2006","journal-title":"Archivos de Cardiolog\u00eda de M\u00e9xico"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2007.12.055_bib14","first-page":"539","article-title":"Clinical evidence on polymer-based sirolimus and paclitaxel eluting stents","volume":"54","author":"Iijima","year":"2006","journal-title":"Minerva Cardioangiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2007.12.055_bib15","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1161\/01.CIR.94.7.1690","article-title":"Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries","volume":"94","author":"van der Giessen","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2007.12.055_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/ccd.20926","article-title":"Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries","volume":"69","author":"Ge","year":"2007","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2007.12.055_bib17","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.ATV.14.6.982","article-title":"Rat aortic smooth muscle cells isolated from different layers and at different times after endothelial denudation show distinct biological features in vitro","volume":"14","author":"Orlandi","year":"1994","journal-title":"Arterioscler Thromb"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2007.12.055_bib18","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0344-0338(85)80103-5","article-title":"Arterial remodeling following mechanical injury. The role and nature of smooth muscle cells","volume":"180","author":"K\u00e1d\u00e1r","year":"1985","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.atherosclerosis.2007.12.055_bib19","first-page":"289","article-title":"Comparison of different de-endothelization procedures in the isolated rat thoracic aorta: a short communication","volume":"113\u2013114","author":"Uluoglu","year":"2003","journal-title":"Res Commun Mol Pathol Pharmacol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2007.12.055_bib20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbrc.2005.02.062","article-title":"PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury","volume":"329","author":"Chen","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2007.12.055_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000096037","article-title":"Inhibition of restenosis development after mechanical injury: a new field of application for malononitrilamides?","volume":"108","author":"Schrepfer","year":"2006","journal-title":"Cardiology"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2007.12.055_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1583\/04-1466.1","article-title":"Commentary: rat restenosis models: means for thorough restenosis research","volume":"12","author":"Langeveld","year":"2005","journal-title":"J Endovasc Ther"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2007.12.055_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000080891","article-title":"Rat abdominal aorta stenting: a new and reliable small animal model for in-stent restenosis","volume":"41","author":"Langeveld","year":"2004","journal-title":"J Vasc Res"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2007.12.055_bib24","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0002-9149(01)01795-7","article-title":"Rat aortic stenting: toward a simple model of in-stent restenosis","volume":"88","author":"Lowe","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2007.12.055_bib25","article-title":"Effects of angiotensin II and angiotensin II type 1 receptor blockade on neointimal formation after stent implantation","author":"Groenewegen","year":"2007","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2007.12.055_bib26","first-page":"215","article-title":"Leflunomide in clinical practice","volume":"31","author":"Pinto","year":"2006","journal-title":"Acta Reumatol\u00f3gica Portuguesa"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2007.12.055_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1517\/13543784.6.1.51","article-title":"Leflunomide and malononitriloamides","volume":"6","author":"Silva","year":"1997","journal-title":"Expert Opin Investig Drugs"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2007.12.055_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1540-8183.2003.01050.x","article-title":"Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus CarboStent","volume":"16","author":"Bartorelli","year":"2003","journal-title":"J Interv Cardiol"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2007.12.055_bib29","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00029330-200704010-00005","article-title":"Midterm outcomes of prospective, randomized, single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions","volume":"120","author":"Han","year":"2007","journal-title":"Chin Med J"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2007.12.055_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0165-2478(95)02464-6","article-title":"Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine","volume":"48","author":"Nair","year":"1995","journal-title":"Immunol Lett"},{"issue":"Suppl 1","key":"10.1016\/j.atherosclerosis.2007.12.055_bib31","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1007\/s001470050494","article-title":"Malononitrilamides synergistically prevent acute and treat ongoing skin allograft rejection with cyclosporine","volume":"11","author":"Schorlemmer","year":"1998","journal-title":"Transpl Int"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2007.12.055_bib32","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2007.12.055_bib33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"N Engl J Med"},{"issue":"9390","key":"10.1016\/j.atherosclerosis.2007.12.055_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0140-6736(03)14462-5","article-title":"Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS)","volume":"362","author":"Schofer","year":"2003","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2007.12.055_bib35","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jacc.2004.01.024","article-title":"The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS)","volume":"43","author":"Schampaert","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2007.12.055_bib36","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/01.CIR.0000156334.24955.B2","article-title":"Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: 3-year results of the RAVEL trial","volume":"111","author":"Fajadet","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2007.12.055_bib37","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1136\/hrt.2005.062992","article-title":"Percutaneous coronary interventions with drug eluting stents for diabetic patients","volume":"92","author":"Seabra-Gomes","year":"2006","journal-title":"Heart"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2007.12.055_bib38","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/hc4201.098056","article-title":"Sustained suppression of neointimal proliferation by sirolimus-eluting stents: 1-year angiographic and intravascular ultrasound follow-up","volume":"104","author":"Sousa","year":"2001","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.atherosclerosis.2007.12.055_bib39","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/01.CIR.0000103666.25660.77","article-title":"Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis","volume":"108","author":"Degertekin","year":"2003","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.atherosclerosis.2007.12.055_bib40","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1161\/01.CIR.0000164271.01172.1A","article-title":"Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents","volume":"111","author":"Sousa","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2007.12.055_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2005.03.069","article-title":"The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)","volume":"46","author":"Serruys","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2007.12.055_bib42","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/eurheartj\/ehl554","article-title":"A look at drug eluting stents with optical coherence tomography","volume":"28","author":"de Smet","year":"2007","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2007.12.055_bib43","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1540-8183.2006.00201.x","article-title":"Clinical applications of optical coherence tomography","volume":"19","author":"Pinto","year":"2006","journal-title":"J Interv Cardiol"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2007.12.055_bib44","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/eurheartj\/ehl413","article-title":"Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography","volume":"28","author":"Matsumoto","year":"2007","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2007.12.055_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ultrasmedbio.2006.07.020","article-title":"Comparison of nonuniform rotational distortion between mechanical IVUS and OCT using a phantom model","volume":"33","author":"Kawase","year":"2007","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2007.12.055_bib46","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0735-1097(92)90476-4","article-title":"Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model","volume":"19","author":"Schwartz","year":"1992","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2007.12.055_bib47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.fjc.0000248233.22570.8b","article-title":"Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells","volume":"48","author":"Matter","year":"2006","journal-title":"J Cardiov Pharmacol"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2007.12.055_bib48","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/00007890-200111150-00018","article-title":"Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide","volume":"72","author":"Waldman","year":"2001","journal-title":"Transplantation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008000038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008000038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T19:01:48Z","timestamp":1557342108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915008000038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0021915008000038"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.12.055","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}